Competition is expected to be activated between ‘Gardasil’ and ‘Cervarix’

Published: 2016-01-04 14:45:36

Updated: 2016-01-04 14:45:36

Due to the NIP expansion, the competition between the two cervical cancer vaccines, ‘Gardasil’ and ‘Cervarix,’ will get fiercer.

The Ministry of Health and Welfare(MOHW), recently, announced that it added the ‘cervical cancer vaccination’ of 2016 to the National Immunization Program for children under 12 through the 2016 First Half’s MOHW Policy Plan.

As the cervical cancer vaccination, which...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.